The broad category of interstitial lung disease (ILD) comprises idiopathic and non-idiopathic pulmonary fibrosis (IPF), with the latter making up most of the cases. Yet, determining which form of non-IPF a patient has is challenging for physicians because there are more than 200 non-IPF ILDs.

The ATS Fellows Track Symposium, Resident Boot Camp, and Student Scholars Program have become so popular with early career professionals that attendance has increased each year.

Celebrate the achievements of four expert researchers for their outstanding scientific contributions in basic or clinical research that enhances the understanding, prevention, and treatment of lung disease during the Recognition Awards for Scientific Accomplishments.

Levels of ventilator-assisted pneumonia (VAP) have declined but remain a concern, so the Centers for Disease Control and Prevention has proposed changes to the monitoring of complications from ventilators. The changes focus on ventilator-associated complications (VAC), which may affect VAP.

With an assortment of hors d’oeuvres, music, and dancing the ATS Foundation kicked off its Eighth Annual Research Program Benefit on Saturday evening.

Patients and families are central to the mission of the American Thoracic Society. With a theme of empowering patients with technology, experts in pulmonary, critical care, and sleep medicine shared their insights with patients and family members during the Public Advisory Roundtable Meet-the-Experts Forum on Saturday.

Q: What have you found most gratifying during your term as president?

A: My focus has been on the next generation, and attracting and attaining top talent in the field.

The ATS Keynote Series continues Monday with discussions about lung cancer detection and prevention, and the evolution of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH).